Ignite Creation Date:
2025-12-25 @ 3:26 AM
Ignite Modification Date:
2025-12-26 @ 2:06 AM
Study NCT ID:
NCT06841705
Status:
RECRUITING
Last Update Posted:
2025-11-04
First Post:
2025-02-11
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Early Vedolizumab as First-Line for Immune-Related Colitis Therapy Trial
Sponsor:
Shilpa Grover, MD, MPH
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-07-15
Start Date Type:
ACTUAL
Primary Completion Date:
2026-07-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2025-02-11
First Submit QC Date:
None
Study First Post Date:
2025-02-24
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-01
Last Update Post Date:
2025-11-04
Last Update Post Date Type:
ESTIMATED